— Know what they know.
Not Investment Advice

TNDM NASDAQ

Tandem Diabetes Care, Inc.
1W: +5.0% 1M: -19.8% 3M: +7.0% YTD: -23.4% 1Y: +33.0% 3Y: -20.7% 5Y: -86.7%
$16.50
+0.00 (+0.00%)
 
Weekly Expected Move ±8.7%
$14 $15 $16 $18 $19
NASDAQ · Healthcare · Medical - Devices · Tech Score Sell · Power 34 · $1.1B mcap · 63M float · 3.40% daily turnover · Short 59% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
46.6 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -8.2%  ·  5Y Avg: -87.3%
Cost Advantage ★
68
Intangibles
55
Switching Cost
27
Network Effect
48
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. TNDM shows a Weak competitive edge (46.6/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. Negative ROIC of -8.2% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$26
Low
$33
Avg Target
$40
High
Based on 2 analysts since Aug 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 24Hold: 15Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$28.00
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-07 RBC Capital Kendall Au $30 $26 -4 +28.9% $20.18
2026-08-07 Canaccord Genuity William Plovanic $35 $40 +5 +112.9% $18.79
2026-07-28 UBS — $22 $18 -4 +0.8% $17.86
2026-06-23 Deutsche Bank — Initiated $16 — +8.1% $14.34
2026-05-31 Wells Fargo — $45 $27 -18 +57.0% $17.20
2026-05-27 Goldman Sachs — $28 $21 -7 +44.4% $14.54
2026-05-11 Barclays — $56 $55 -1 +255.3% $15.48
2026-05-08 Mizuho Securities Anthony Petrone $22 $24 +2 +29.9% $18.47
2026-04-24 Redburn Partners Issie Kirby Initiated $45 — +117.6% $20.68
2026-02-23 Truist Financial — $24 $27 +3 +9.9% $24.57
2026-02-23 Lake Street — $75 $50 -25 +103.5% $24.57
2026-02-23 Goldman Sachs David Roman $25 $28 +3 +14.0% $24.57
2026-02-23 Barclays Matt Miksic $53 $56 +3 +127.9% $24.57
2026-02-20 Mizuho Securities — $21 $22 +1 +18.8% $18.52
2026-02-20 Stifel Nicolaus — $20 $22 +2 +18.8% $18.52
2026-02-20 UBS — $160 $22 -138 +18.8% $18.52
2026-02-20 Piper Sandler Matt O'Brien $14 $21 +7 +13.4% $18.52
2026-02-04 Stifel Nicolaus — $60 $20 -40 +4.7% $19.11
2026-01-09 Goldman Sachs David Roman Initiated $25 — +11.1% $22.50
2025-12-18 Truist Financial — $16 $24 +8 +8.0% $22.22
2025-12-17 RBC Capital — $65 $30 -35 +31.5% $22.81
2025-12-17 Canaccord Genuity William Plovanic $24 $35 +11 +54.9% $22.60
2025-12-17 Mizuho Securities Anthony Petrone Initiated $21 — -7.1% $22.60
2025-12-16 Robert W. Baird — $37 $30 -7 +35.6% $22.12
2025-12-02 Morgan Stanley — $22 $23 +1 +12.1% $20.51
2025-10-15 Truist Financial Richard Newitter Initiated $16 — +5.9% $15.11
2025-09-08 Oppenheimer Suraj Kalia $58 $22 -36 +76.0% $12.50
2025-08-07 Canaccord Genuity William Plovanic $57 $24 -33 +114.4% $11.20
2025-08-07 Piper Sandler Matt O'Brien $55 $14 -41 -2.7% $14.39
2025-03-05 Morgan Stanley — Initiated $22 — +15.1% $19.11
2025-02-28 Bernstein — $44 $25 -19 +12.9% $22.14
2025-02-28 Barclays — $58 $53 -5 +139.4% $22.14
2025-01-08 Bernstein Lee Hambright $42 $44 +2 +17.4% $37.49
2024-11-07 Robert W. Baird Jeff Johnson $39 $37 -2 +12.6% $32.87
2024-11-05 Bernstein Lee Hambright Initiated $42 — +26.8% $33.11
2024-10-02 RBC Capital Shagun Singh Initiated $65 — +58.3% $41.07
2024-08-08 Canaccord Genuity William Plovanic Initiated $57 — +53.9% $37.04
2024-08-05 Barclays Matt Miksic Initiated $58 — +39.2% $41.67
2024-08-02 Piper Sandler Matt O'Brien $50 $55 +5 +56.2% $35.21
2024-08-02 Robert W. Baird Jeff Johnson $36 $39 +3 +10.8% $35.21
2024-06-10 Oppenheimer Steven Lichtman Initiated $58 — +23.3% $47.03
2024-05-29 Stifel Nicolaus Matthew Blackman $40 $60 +20 +15.5% $51.93
2024-05-22 Lake Street Brooks O'Neil Initiated $75 — +52.1% $49.32
2024-05-03 Piper Sandler Matt O'Brien $80 $50 -30 +36.8% $36.56
2024-05-03 Robert W. Baird Jeff Johnson Initiated $36 — -1.5% $36.56
2024-04-29 Wells Fargo Lawrence Biegelsen $49 $45 -4 +19.8% $37.55
2024-04-25 Leerink Partners Danielle AntalffyMike Kratky Initiated $45 — +27.3% $35.35
2024-04-22 Stifel Nicolaus Matthew Blackman $37 $40 +3 +26.1% $31.73
2024-04-11 CFRA Kenneth Leon Initiated $36 — +6.3% $33.87
2024-03-25 Stifel Nicolaus Mathew Blackman Initiated $37 — +22.9% $30.10

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
Oct 02, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. TNDM receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 23 Grade D
Profitability
17
Balance Sheet
38
Earnings Quality
56
Growth
62
Value
30
Momentum
61
Safety
15
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. TNDM scores highest in Growth (62/100) and lowest in Safety (15/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.36
Distress Zone
Piotroski F-Score
4/9
✗ ✗ ✓ ✓ ✗ ✓ ✗ ✓ ✗
Beneish M-Score
-2.25
Unlikely Manipulator
Ohlson O-Score
-4.97
Bankruptcy prob: 0.7%
Low Risk
Credit Rating
B
Score: 27.4/100
Trend: Stable
Earnings Quality
—
OCF/NI: 0.09x
Accruals: -5.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. TNDM scores 0.36, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. TNDM scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. TNDM's score of -2.25 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. TNDM's implied 0.7% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. TNDM receives an estimated rating of B (score: 27.4/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-17.77x
PEG
-0.17x
P/S
1.09x
P/B
8.66x
P/FCF
-38.77x
P/OCF
—
EV/EBITDA
-43.39x
EV/Revenue
1.26x
EV/EBIT
-24.92x
EV/FCF
-49.42x
Earnings Yield
-6.13%
FCF Yield
-2.58%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. TNDM currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.038
NI / EBT
×
Interest Burden
1.156
EBT / EBIT
×
EBIT Margin
-0.051
EBIT / Rev
×
Asset Turnover
1.026
Rev / Assets
×
Equity Multiplier
7.699
Assets / Equity
=
ROE
-48.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. TNDM's ROE of -48.0% is driven by financial leverage (equity multiplier: 7.70x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.04 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$16.50
Median 1Y
$11.14
5th Pctile
$3.91
95th Pctile
$31.87
Ann. Volatility
64.4%
Analyst Target
$28.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
John Sheridan
President and Chief Executive Officer
$790,583 $5,367,796 $6,858,503
Mark Novara President,
Vice President, Chief Commercial Officer
$486,220 $1,417,854 $2,204,612
Leigh Vosseller President,
Vice President, Chief Financial Officer and Treasurer
$486,220 $1,417,854 $2,181,894
Elizabeth Gasser President,
Vice President, Chief Strategy and Product Officer
$463,710 $1,035,730 $1,747,944
Shannon Hansen President,
Vice President, Chief Legal, Privacy and Compliance Officer and Secretary
$463,710 $1,035,730 $1,747,901

CEO Pay Ratio

39:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $6,858,503
Avg Employee Cost (SGA/emp): $173,654
Employees: 2,500

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
2,500
-5.7% YoY
Revenue / Employee
$405,894
Rev: $1,014,736,000
Profit / Employee
$-81,884
NI: $-204,710,000
SGA / Employee
$173,654
Avg labor cost proxy
R&D / Employee
$69,934
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 6.1% 3.9% 1.6% -3.3% -16.7% -21.7% -52.5% -57.6% -56.7% -59.1% -48.6% -48.5% -46.0% -33.3% -92.3% -1.1% -1.1% -97.9% -65.7% -48.0% -48.03%
ROA 2.9% 1.9% 0.7% -1.4% -7.2% -9.7% -20.7% -22.6% -21.0% -22.2% -14.9% -14.5% -13.4% -10.0% -19.7% -22.7% -22.2% -22.1% -9.1% -6.2% -6.24%
ROIC 25.8% 17.9% 6.1% -2.4% -20.9% -30.2% -67.7% -75.6% -72.9% -70.5% -46.0% -42.5% -43.9% -26.2% -50.3% -59.0% -58.0% -47.5% -21.6% -8.2% -8.21%
ROCE 4.1% 2.7% 1.0% -0.9% -7.0% -9.9% -24.9% -28.0% -26.2% -28.0% -17.0% -17.5% -16.7% -11.8% -26.4% -31.2% -31.7% -30.1% -9.9% -5.9% -5.86%
Gross Margin 53.9% 54.2% 51.8% 50.9% 51.1% 52.4% 48.9% 51.9% 48.4% 47.4% 49.4% 50.8% 34.3% 55.7% 50.5% 52.3% 53.9% 57.7% 55.3% 56.9% 56.87%
Operating Margin 4.3% 6.1% -8.7% -6.1% -23.2% -8.1% -75.5% -19.8% -17.0% -17.8% -21.7% -13.9% -7.2% -0.2% -51.6% -21.5% -8.0% 2.9% -7.1% -5.4% -5.42%
Net Margin 3.2% 5.1% -8.4% -7.5% -23.9% -7.2% -73.1% -18.3% -17.8% -15.2% -22.3% -13.9% -6.4% 0.3% -55.7% -21.8% -8.5% -0.2% -8.2% -8.3% -8.32%
EBITDA Margin 5.7% 7.5% -6.7% -4.2% -20.7% -5.2% -70.3% -14.7% -12.2% -13.0% -17.8% -10.7% -4.6% 2.2% -49.7% -21.1% -7.5% 3.9% -5.6% -3.6% -3.63%
FCF Margin 12.9% 12.5% 10.0% 6.6% 3.8% 2.0% -3.0% -4.2% -6.3% -11.2% -8.7% -8.1% -3.8% 0.5% -0.3% -0.7% -2.5% -2.9% -0.4% -2.6% -2.56%
OCF Margin 16.2% 15.8% 13.1% 9.7% 8.1% 6.3% 2.3% 0.6% -2.4% -4.3% -2.8% -2.6% 0.6% 2.3% 1.3% 0.9% -0.9% -1.0% 1.9% -0.5% -0.53%
ROE 3Y Avg snapshot only -87.02%
ROE 5Y Avg snapshot only -66.44%
ROA 3Y Avg snapshot only -14.50%
ROIC 3Y Avg snapshot only -83.36%
ROIC Economic snapshot only -4.00%
Cash ROA snapshot only -0.48%
Cash ROIC snapshot only -1.34%
CROIC snapshot only -6.43%
NOPAT Margin snapshot only -3.26%
Pretax Margin snapshot only -5.86%
R&D / Revenue snapshot only 17.95%
SGA / Revenue snapshot only 42.19%
SBC / Revenue snapshot only 6.98%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 355.45 637.50 1260.15 -288.01 -45.25 -30.59 -12.87 -7.09 -6.49 -8.69 -16.35 -19.19 -21.92 -24.82 -6.92 -6.08 -4.04 -7.30 -13.87 -16.30 -17.767
P/S Ratio 11.70 14.12 10.07 4.95 3.89 3.61 3.30 2.01 1.75 2.59 3.00 3.29 2.85 2.25 1.15 1.11 0.82 1.47 1.28 0.99 1.086
P/B Ratio 19.85 22.91 16.98 8.44 7.29 6.58 7.74 4.83 4.31 6.17 9.52 11.20 11.69 9.06 8.19 9.38 6.18 9.63 9.90 7.92 8.655
P/FCF 90.88 112.96 100.60 74.55 102.24 176.82 -109.48 -48.29 -27.87 -23.18 -34.67 -40.76 -74.41 477.17 -335.17 -161.12 -32.69 -50.39 -360.21 -38.77 -38.775
P/OCF 72.31 89.11 77.00 50.92 47.82 57.35 142.95 311.09 — — — — 441.75 98.37 91.25 128.56 — — 66.86 — —
EV/EBITDA 170.46 278.78 314.62 594.80 -61.99 -36.59 -13.93 -7.46 -7.00 -9.60 -20.94 -24.93 -27.82 -35.40 -9.27 -7.79 -5.29 -9.43 -20.52 -43.39 -43.394
EV/Revenue 11.28 13.68 9.78 4.67 3.65 3.37 3.17 1.90 1.65 2.52 3.02 3.32 2.86 2.28 1.27 1.23 0.94 1.62 1.44 1.26 1.263
EV/EBIT 248.65 465.76 807.12 -442.85 -47.50 -30.63 -12.92 -6.95 -6.45 -8.89 -18.25 -21.62 -23.90 -28.48 -8.34 -7.10 -4.83 -8.57 -16.44 -24.92 -24.923
EV/FCF 87.60 109.44 97.67 70.35 96.03 164.79 -105.34 -45.65 -26.23 -22.55 -34.82 -41.15 -74.48 484.22 -367.99 -178.35 -37.87 -55.50 -405.40 -49.42 -49.416
Earnings Yield 0.3% 0.2% 0.1% -0.3% -2.2% -3.3% -7.8% -14.1% -15.4% -11.5% -6.1% -5.2% -4.6% -4.0% -14.5% -16.4% -24.8% -13.7% -7.2% -6.1% -6.13%
FCF Yield 1.1% 0.9% 1.0% 1.3% 1.0% 0.6% -0.9% -2.1% -3.6% -4.3% -2.9% -2.5% -1.3% 0.2% -0.3% -0.6% -3.1% -2.0% -0.3% -2.6% -2.58%
Price/Tangible Book snapshot only 7.916
EV/Gross Profit snapshot only 2.255
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 6.31 6.15 6.21 6.00 4.81 5.14 4.43 4.38 4.05 3.83 3.81 3.05 2.90 2.93 2.30 2.44 2.44 2.55 3.58 3.18 3.180
Quick Ratio 5.76 5.63 5.60 5.36 4.20 4.47 3.66 3.53 3.28 3.02 3.01 2.38 2.32 2.33 1.81 1.88 1.90 2.02 3.07 2.65 2.646
Debt/Equity 0.81 0.73 0.96 0.94 1.00 0.95 1.24 1.28 1.33 1.33 1.96 2.04 2.00 1.80 3.18 3.37 3.38 2.86 5.55 5.67 5.670
Net Debt/Equity -0.72 -0.71 -0.49 -0.47 -0.44 -0.45 -0.29 -0.26 -0.25 -0.17 0.04 0.11 0.01 0.13 0.80 1.00 0.98 0.98 1.24 2.17 2.172
Debt/Assets 0.37 0.35 0.41 0.41 0.40 0.40 0.44 0.44 0.44 0.44 0.51 0.51 0.50 0.49 0.53 0.51 0.51 0.50 0.64 0.64 0.640
Debt/EBITDA 7.22 9.12 18.29 70.13 -9.06 -5.70 -2.32 -2.09 -2.30 -2.12 -4.30 -4.50 -4.76 -6.93 -3.27 -2.53 -2.50 -2.55 -10.22 -24.39 -24.388
Net Debt/EBITDA -6.38 -8.96 -9.43 -35.44 4.01 2.67 0.55 0.43 0.44 0.27 -0.09 -0.23 -0.03 -0.52 -0.83 -0.75 -0.72 -0.87 -2.29 -9.34 -9.345
Interest Coverage 3.22 3.39 1.47 -1.32 -9.82 -14.18 -30.85 -33.83 -20.41 -21.43 -12.55 -11.83 -15.82 -11.45 -24.37 -25.57 -25.21 -23.93 -10.81 -6.42 -6.422
Equity Multiplier 2.18 2.09 2.32 2.31 2.48 2.39 2.82 2.88 2.99 3.04 3.87 4.01 4.03 3.68 5.94 6.57 6.58 5.68 8.71 8.85 8.852
Cash Ratio snapshot only 1.802
Debt Service Coverage snapshot only -3.688
Cash to Debt snapshot only 0.617
FCF to Debt snapshot only -0.036
Defensive Interval snapshot only 360.2 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.87 0.87 0.83 0.84 0.83 0.82 0.81 0.80 0.78 0.75 0.81 0.84 1.03 1.10 1.18 1.24 1.10 1.10 0.99 1.03 1.026
Inventory Turnover 4.51 4.94 4.68 4.68 4.45 4.32 3.69 3.27 3.07 2.82 2.74 2.62 3.71 3.71 3.99 3.91 3.25 3.37 3.46 3.30 3.299
Receivables Turnover 9.47 7.29 8.79 8.32 7.90 7.11 8.57 7.81 7.24 6.79 8.35 8.09 9.38 9.63 10.04 9.90 8.64 7.25 7.69 7.17 7.170
Payables Turnover 12.97 14.25 9.35 9.27 8.58 9.27 7.75 7.16 7.09 7.22 7.56 7.73 11.55 12.09 10.91 11.48 9.79 10.21 7.74 7.64 7.637
DSO 39 50 42 44 46 51 43 47 50 54 44 45 39 38 36 37 42 50 47 51 50.9 days
DIO 81 74 78 78 82 84 99 112 119 129 133 139 99 98 91 93 112 108 105 111 110.6 days
DPO 28 26 39 39 43 39 47 51 52 51 48 47 32 30 33 32 37 36 47 48 47.8 days
Cash Conversion Cycle 91 98 80 82 86 96 95 107 118 132 129 137 106 106 94 98 117 123 106 114 113.7 days
Fixed Asset Turnover snapshot only 5.639
Operating Cycle snapshot only 161.5 days
Cash Velocity snapshot only 2.284
Capital Intensity snapshot only 1.108
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 50.5% 40.9% 36.1% 26.6% 19.6% 14.0% 7.7% 3.2% -2.4% -6.7% -3.1% 0.7% 26.2% 41.7% 43.2% 40.8% 3.4% -4.2% -6.8% -7.1% -7.10%
Net Income 1.4% 1.5% 1.2% -3.0% -4.1% -7.1% -35.6% -16.0% -2.1% -1.4% 30.6% 39.2% 39.2% 56.9% -30.0% -50.5% -60.4% -1.1% 48.6% 69.2% 69.18%
EPS 1.4% 1.5% 1.2% -3.1% -4.1% -7.2% -35.2% -15.8% -2.0% -1.3% 31.4% 39.3% 39.6% 57.4% -27.9% -45.9% -55.4% -1.1% 50.1% 69.8% 69.79%
FCF 15.0% 12.5% 64.3% -17.6% -64.7% -81.4% -1.3% -1.6% -2.6% -6.1% -1.8% -95.0% 23.0% 1.1% 94.3% 87.9% 32.7% -6.9% 4.1% -2.4% -2.43%
EBITDA 2.3% 3.6% 35.5% -81.1% -2.1% -3.1% -8.9% -34.5% -2.9% -1.7% 38.7% 47.4% 45.0% 65.1% -35.8% -67.5% -79.7% -1.6% 52.3% 82.9% 82.94%
Op. Income 2.2% 3.8% 3.4% -1.4% -3.2% -5.1% -20.5% -31.6% -2.5% -1.5% 28.4% 40.0% 38.1% 57.5% -21.2% -43.4% -44.7% -86.1% 54.6% 78.4% 78.43%
OCF Growth snapshot only -1.57%
Asset Growth snapshot only 31.80%
Equity Growth snapshot only -2.17%
Debt Growth snapshot only 64.64%
Shares Change snapshot only 2.01%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 64.7% 56.4% 49.1% 39.6% 33.8% 30.3% 26.3% 24.4% 20.7% 14.4% 12.4% 9.6% 13.8% 14.7% 14.3% 13.5% 8.4% 8.2% 8.9% 9.6% 9.63%
Revenue 5Y 50.9% 52.8% 54.7% 56.5% 52.4% 49.4% 47.0% 43.8% 39.1% 32.4% 28.2% 23.1% 24.2% 23.9% 22.8% 22.3% 18.1% 15.3% 13.6% 11.5% 11.48%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y 75.1% 61.2% 52.2% 40.1% 32.8% 28.6% 24.2% 23.3% 19.2% 12.2% 10.2% 6.7% 6.4% 9.2% 9.2% 9.3% 9.2% 9.8% 11.7% 13.0% 12.97%
Gross Profit 5Y 67.2% 74.0% 75.9% 77.0% 62.1% 56.4% 52.7% 48.6% 42.8% 32.6% 27.7% 21.6% 19.4% 20.3% 19.4% 19.5% 18.4% 16.0% 14.8% 12.6% 12.65%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — 8.9% 9.5% -9.9% — — — — — — — -61.5% — — — — — — —
FCF 5Y — — — — — — — — — — — — — -25.9% — — — — — — —
OCF 3Y — — — 94.5% 20.7% 6.4% -10.3% -48.4% — — — — -61.1% -39.9% -47.5% -49.3% — — 2.3% — —
OCF 5Y — — — — — — — — — — — — -29.7% -10.4% -11.3% -23.6% — — -23.3% — —
Assets 3Y 67.3% 63.7% 67.8% 59.6% 53.0% 47.8% 40.6% 15.4% 11.8% 10.0% 7.7% 5.6% 4.0% 2.3% -3.2% -5.5% -5.8% -5.8% 6.5% 6.8% 6.83%
Assets 5Y 56.6% 51.8% 55.2% 60.1% 64.1% 61.7% 45.8% 43.1% 38.9% 35.8% 34.4% 29.7% 26.8% 24.3% 21.8% 7.3% 5.4% 4.2% 8.9% 7.7% 7.73%
Equity 3Y 50.0% 48.9% 53.5% 45.7% 36.2% 31.2% 17.8% 7.1% -1.3% -5.0% -8.1% -12.2% -15.2% -15.3% -29.2% -33.3% -31.9% -29.3% -26.9% -26.6% -26.56%
Book Value 3Y 42.6% 45.0% 48.4% 41.1% 32.5% 30.1% 14.8% 4.7% -3.1% -4.9% -9.5% -11.9% -15.5% -15.4% -30.1% -34.3% -33.1% -30.6% -28.3% -27.9% -27.86%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.90 0.93 0.96 0.98 0.98 0.99 0.99 0.97 0.94 0.89 0.89 0.88 0.94 0.89 0.88 0.88 0.93 0.86 0.85 0.84 0.836
Earnings Stability 0.48 0.60 0.68 0.78 0.24 0.10 0.03 0.05 0.07 0.17 0.19 0.36 0.51 0.43 0.65 0.60 0.64 0.57 0.29 0.21 0.209
Margin Stability 0.80 0.77 0.77 0.77 0.87 0.89 0.90 0.92 0.93 0.96 0.97 0.97 0.92 0.94 0.94 0.95 0.92 0.94 0.94 0.93 0.931
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.84 0.84 0.50 0.88 0.50 0.50 0.50 0.81 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 0.20 0.15 0.09 0.04 -0.11 -0.19 -0.57 -0.68 -0.61 -0.62 -0.29 -0.23 -0.12 0.10 -0.59 -0.91 -0.93 -0.78 0.17 0.58 0.577
Gross Margin Trend 0.01 0.01 0.00 -0.00 -0.01 -0.01 -0.02 -0.02 -0.02 -0.03 -0.03 -0.03 -0.08 -0.04 -0.04 -0.03 0.06 0.06 0.07 0.08 0.080
FCF Margin Trend 0.10 0.10 0.06 0.01 -0.02 -0.03 -0.12 -0.13 -0.15 -0.18 -0.12 -0.09 -0.03 0.05 0.05 0.05 0.03 0.02 0.04 0.02 0.018
Sustainable Growth Rate 6.1% 3.9% 1.6% — — — — — — — — — — — — — — — — — —
Internal Growth Rate 2.9% 2.0% 0.7% — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 4.92 7.15 16.37 -5.66 -0.95 -0.53 -0.09 -0.02 0.09 0.14 0.15 0.15 -0.05 -0.25 -0.08 -0.05 0.04 0.05 -0.21 0.09 0.087
FCF/OCF 0.80 0.79 0.77 0.68 0.47 0.32 -1.31 -6.44 2.58 2.62 3.11 3.14 -5.94 0.21 -0.27 -0.80 2.86 3.05 -0.19 4.82 4.819
FCF/Net Income snapshot only 0.420
CapEx/Revenue 3.3% 3.3% 3.1% 3.1% 4.3% 4.3% 5.3% 4.8% 3.9% 6.9% 5.9% 5.5% 4.5% 1.8% 1.6% 1.6% 1.6% 2.0% 2.3% 2.0% 2.03%
CapEx/Depreciation snapshot only 0.939
Accruals Ratio -0.11 -0.12 -0.10 -0.10 -0.14 -0.15 -0.23 -0.23 -0.19 -0.19 -0.13 -0.12 -0.14 -0.13 -0.21 -0.24 -0.21 -0.21 -0.11 -0.06 -0.057
Sloan Accruals snapshot only 0.164
Cash Flow Adequacy snapshot only -0.262
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% — — — — — — — — — — — — — — — — — —
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — — — — — 0.0% — — — — — — —
Total Payout Ratio 0.0% 0.0% 0.0% — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.3% 1.3% 1.2% 1.4% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% -0.2% -0.3% -0.7% -0.9% -0.6% -0.5% -0.4% -0.3% -0.1% 1.2% 1.1% 1.0% 1.2% -0.3% -0.6% -0.5% -0.2% -0.1% -0.1% -0.10%
Total Shareholder Return 0.0% -0.2% -0.3% -0.7% -0.9% -0.6% -0.5% -0.4% -0.3% -0.1% 1.2% 1.1% 1.0% 1.2% -0.3% -0.6% -0.5% -0.2% -0.1% -0.1% -0.10%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 0.98 1.28 1.06 1.04 1.02 1.02 1.01 1.02 1.01 1.04 1.04 1.03 1.05 1.05 1.02 0.99 1.02 0.96 1.04 1.038
Interest Burden (EBT/EBIT) 0.73 0.77 0.52 1.53 1.08 1.05 1.02 1.02 1.04 1.04 1.07 1.07 1.06 1.08 1.04 1.04 1.04 1.04 1.09 1.16 1.156
EBIT Margin 0.05 0.03 0.01 -0.01 -0.08 -0.11 -0.25 -0.27 -0.26 -0.28 -0.17 -0.15 -0.12 -0.08 -0.15 -0.17 -0.20 -0.19 -0.09 -0.05 -0.051
Asset Turnover 0.87 0.87 0.83 0.84 0.83 0.82 0.81 0.80 0.78 0.75 0.81 0.84 1.03 1.10 1.18 1.24 1.10 1.10 0.99 1.03 1.026
Equity Multiplier 2.13 2.03 2.36 2.30 2.34 2.24 2.54 2.55 2.70 2.66 3.26 3.35 3.44 3.33 4.68 4.94 4.94 4.42 7.21 7.70 7.699
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.34 $0.24 $0.09 $-0.21 $-1.06 $-1.47 $-3.16 $-3.46 $-3.20 $-3.41 $-2.17 $-2.10 $-1.93 $-1.45 $-2.77 $-3.06 $-3.01 $-3.01 $-1.38 $-0.93 $-0.93
Book Value/Share $6.01 $6.57 $6.85 $7.02 $6.57 $6.83 $5.25 $5.08 $4.82 $4.80 $3.72 $3.60 $3.63 $3.98 $2.34 $1.99 $1.97 $2.28 $1.94 $1.91 $1.91
Tangible Book/Share $6.01 $6.47 $6.85 $7.02 $6.57 $6.76 $5.25 $5.08 $4.82 $4.76 $3.72 $3.60 $3.63 $3.96 $2.34 $1.99 $1.97 $2.28 $1.94 $1.91 $1.91
Revenue/Share $10.20 $10.66 $11.55 $11.95 $12.31 $12.44 $12.31 $12.19 $11.85 $11.44 $11.79 $12.25 $14.86 $16.02 $16.60 $16.72 $14.89 $14.92 $15.02 $15.23 $15.23
FCF/Share $1.31 $1.33 $1.16 $0.79 $0.47 $0.25 $-0.37 $-0.51 $-0.75 $-1.28 $-1.02 $-0.99 $-0.57 $0.08 $-0.06 $-0.12 $-0.37 $-0.44 $-0.05 $-0.39 $-0.39
OCF/Share $1.65 $1.69 $1.51 $1.16 $1.00 $0.78 $0.28 $0.08 $-0.29 $-0.49 $-0.33 $-0.31 $0.10 $0.37 $0.21 $0.14 $-0.13 $-0.14 $0.29 $-0.08 $-0.08
Cash/Share $9.18 $9.46 $9.95 $9.91 $9.48 $9.58 $8.05 $7.82 $7.65 $7.16 $7.16 $6.96 $7.22 $6.63 $5.55 $4.70 $4.72 $4.30 $8.34 $6.67 $6.67
EBITDA/Share $0.68 $0.52 $0.36 $0.09 $-0.73 $-1.14 $-2.81 $-3.11 $-2.79 $-3.00 $-1.70 $-1.63 $-1.53 $-1.03 $-2.27 $-2.65 $-2.66 $-2.57 $-1.05 $-0.44 $-0.44
Debt/Share $4.88 $4.77 $6.56 $6.59 $6.57 $6.52 $6.51 $6.48 $6.42 $6.36 $7.31 $7.34 $7.26 $7.16 $7.43 $6.70 $6.64 $6.54 $10.74 $10.81 $10.81
Net Debt/Share $-4.31 $-4.69 $-3.38 $-3.33 $-2.91 $-3.06 $-1.54 $-1.34 $-1.23 $-0.80 $0.15 $0.38 $0.04 $0.53 $1.88 $1.99 $1.92 $2.23 $2.40 $4.14 $4.14
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 0.360
Altman Z-Prime snapshot only 0.231
Piotroski F-Score 7 7 6 4 4 4 3 4 2 1 3 3 4 5 4 4 3 3 5 4 4
Beneish M-Score -2.22 -2.49 -2.44 -2.63 -2.67 -2.96 -3.57 -3.66 -3.63 -3.10 -2.48 -2.56 -1.94 -2.56 -2.80 -2.83 -2.88 -3.12 -2.85 -2.25 -2.252
Ohlson O-Score snapshot only -4.974
ROIC (Greenblatt) snapshot only -7.17%
Net-Net WC snapshot only $-3.20
EVA snapshot only $-75330550.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only B
Credit Score 72.35 72.53 59.32 55.38 56.50 57.88 44.69 35.62 34.34 34.72 37.92 36.68 42.41 45.58 27.33 27.64 22.09 30.77 28.68 27.44 27.442
Credit Grade snapshot only 15
Credit Trend snapshot only -0.200
Implied Spread (bps) snapshot only 750.000
Industry Credit Rank snapshot only 17
Sector Credit Rank snapshot only 18

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms